Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly Bolotin

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Lancet Regional Health. Americas|November 7, 2024
Burden of infant group B <i>Streptococcus</i> disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort studyRomina Fakhraei, Deshayne B Fell, Darine El-Chaâr, et al.
Lancet Regional Health. Americas|July 21, 2025
Group B <i>Streptococcus</i> disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, CanadaRomina Fakhraei, Deshayne B Fell, Darine El-Chaâr, et al.
Vaccine|April 20, 2021
A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network studyRachel D Savage, Christopher A Bell, Christiaan H Righolt, et al.
BMC Public Health|May 27, 2026
Vaccination attitudes and intentions reported by Canadian children and their parents in the CHILD Cohort Study during the COVID-19 pandemicMaria V Medeleanu, Erin E Gill, Geoffrey L Winsor, et al.
Access Microbiology|July 23, 2025
Comparison of six COVID-19 serology assays for detection of antibodies from patients infected with ancestral and a spectrum of SARS-CoV-2 variantsRachel Lau, Chandrika Senthilkumaran, Jeffrey Chong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2020
A Call for Caution in Use of Pertussis Vaccine Effectiveness Studies to Estimate Waning Immunity: A Canadian Immunization Research Network StudyNatasha S Crowcroft, Kevin L Schwartz, Rachel D Savage, et al.
CMAJ Open|October 13, 2021
SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort studyMichelle Science, Shelly Bolotin, Michael Silverman, et al.
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studiesMarjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, et al.
CMAJ Open|July 5, 2022
Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort studySonia S Anand, Corey Arnold, Shrikant I Bangdiwala, et al.
Human Vaccines & Immunotherapeutics|January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in CanadaTiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Lancet Regional Health. Americas|November 7, 2024
Burden of infant group B <i>Streptococcus</i> disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort studyRomina Fakhraei, Deshayne B Fell, Darine El-Chaâr, et al.
Lancet Regional Health. Americas|July 21, 2025
Group B <i>Streptococcus</i> disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, CanadaRomina Fakhraei, Deshayne B Fell, Darine El-Chaâr, et al.
Vaccine|April 20, 2021
A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network studyRachel D Savage, Christopher A Bell, Christiaan H Righolt, et al.
BMC Public Health|May 27, 2026
Vaccination attitudes and intentions reported by Canadian children and their parents in the CHILD Cohort Study during the COVID-19 pandemicMaria V Medeleanu, Erin E Gill, Geoffrey L Winsor, et al.
Access Microbiology|July 23, 2025
Comparison of six COVID-19 serology assays for detection of antibodies from patients infected with ancestral and a spectrum of SARS-CoV-2 variantsRachel Lau, Chandrika Senthilkumaran, Jeffrey Chong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2020
A Call for Caution in Use of Pertussis Vaccine Effectiveness Studies to Estimate Waning Immunity: A Canadian Immunization Research Network StudyNatasha S Crowcroft, Kevin L Schwartz, Rachel D Savage, et al.
CMAJ Open|October 13, 2021
SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort studyMichelle Science, Shelly Bolotin, Michael Silverman, et al.
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studiesMarjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, et al.
CMAJ Open|July 5, 2022
Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort studySonia S Anand, Corey Arnold, Shrikant I Bangdiwala, et al.
Human Vaccines & Immunotherapeutics|January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in CanadaTiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
Pageof 9